Equity Insider News Commentary - The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source[1]. The ...

The foods you eat (and the ones you don’t) influence the way you age. Leslie Beck offers some tips on how to make the best ...

In conclusion, incorporating fruit granola into the daily diet was associated with favorable changes in blood pressure, ...

Brazil: Researchers have found in a new study that preoperative capillary blood glucose levels show good specificity in ...

Learn how eating pasta regularly affects blood sugar, insulin response, and overall glucose control, plus tips for enjoying ...

Hone Health reports that GLP-1 medications are increasingly prescribed for weight loss and metabolic health, even in those ...

Neither had a great year in 2025, but the future is looking bright.

Supplements like berberine, cinnamon, ginseng, and St. John’s Wort can affect how diabetes medications work. Learn the biggest risks, interactions, and what to tell your healthcare provider before ...

Veracyte stands out in a pressured medical instruments industry as genAI adoption and rising sales forecasts fuel investor interest.

We are mindful that opinion is growing about whether this is caused by the eye itself or a new factor called type III ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...